Large study confirms H1N1 flu shots safe for pregnant women

Norwegian pregnant women who received a vaccine against the 2009 H1N1 influenza virus showed no increased risk of pregnancy loss, while pregnant women who experienced influenza during pregnancy had an increased risk of miscarriages and still births, a study has found. The study suggests that influenza infection may increase the risk of fetal loss.

Scientists at the U.S. National Institutes of Health and the Norwegian Institute of Public Health (NIPH) published their findings online Jan. 17 in the . The research was conducted following the H1N1 that took place between spring 2009 and fall 2010. The researchers at the NIH were from the National Institute of Environmental Health Sciences (NIEHS).

Norwegian had urged pregnant women to be vaccinated. However, media reports of pregnancy losses after flu shots caused some expectant mothers to forgo vaccination.

First author Siri Haberg, M.D., Ph.D., of the NIPH and colleagues initiated the study to help address the question of vaccine safety, by taking advantage of Norway's excellent registries and medical records system. Haberg spent one year of her postdoctoral fellowship in the NIEHS Epidemiology Branch before returning home to Norway during the pandemic.

NIEHS researcher and co-author Allen Wilcox, M.D., Ph.D., said the NIPH researchers combined data from obstetrical visits, birth records, and vaccination registries to investigate whether the influenza vaccination posed a risk to pregnancy. The study found that increased the risk of fetal loss by up to twofold. did not increase the risk of loss. Instead, the results suggest that vaccination reduces the risk of fetal loss.

"Most important is that vaccinations protect pregnant women against influenza illness, which could be harmful for both the mother and the baby," Wilcox said. "If pregnant women are worried about their fetus, then getting a flu shot is a good thing to do."

Haberg added, "Pregnant women should find it reassuring that we found no harmful effects on the fetus associated with H1N1 vaccination."

More information: Haberg SE, Trogstad L, Gunnes N, Wilcox AJ, Gjessing HK, Samuelsen SO, Skrondal A, Cappelen I, Engeland A, Aavitsland P, Madsen S, Buajordet I, Furu K, Nafstad P, Vollset SE, Feiring B, Nokleby H, Magnus P, Stoltenberg C. 2013. Risk of fetal death after pandemic influenza infection or vaccination. N Engl J Med; doi:10.1056/NEJMoa1207210 [Online 17 January 2013].

add to favorites email to friend print save as pdf

Related Stories

Influenza vaccination during pregnancy protects newborns

Jun 23, 2011

Infants born to mothers who received the influenza (flu) vaccine while pregnant are nearly 50 percent less likely to be hospitalized for the flu than infants born to mothers who did not receive the vaccine while pregnant, ...

Recommended for you

Ebola vaccine not before late 2016: GSK researcher

Oct 17, 2014

An Ebola vaccine by British pharmaceuticals giant GlaxoSmithKline may not be ready for commercial use until late 2016 and should therefore not be seen as the "primary answer" to the current outbreak, a company researcher ...

Chimerix gets FDA OK to test drug for Ebola

Oct 17, 2014

(AP)—A North Carolina drugmaker plans to test its experimental antiviral drug in patients who have Ebola, after getting authorization from regulators at the Food and Drug Administration.

Esbriet, ofev approved to treat deadly lung disease

Oct 16, 2014

(HealthDay)—Two new drugs have been approved by the U.S. Food and Drug Administration to treat progressive lung scarring from an uncertain cause, medically called idiopathic pulmonary fibrosis (IPF).

FDA weighs removing bolded warning from Chantix

Oct 14, 2014

(AP)—The Food and Drug Administration will ask a panel of experts later this week whether a bold-letter warning on the anti-smoking drug Chantix should be removed based on company-supported evidence that the drug does not ...

Drug-coated balloon catheter approved

Oct 13, 2014

(HealthDay)—The first drug-coated balloon catheter designed to clear narrowed or blocked arteries in the thigh and knee has been approved by the U.S. Food and Drug Administration.

User comments